Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Operating Expenses | 7,829 | 9,430 | 9,998 | 10,190 | 14,223 |
Operating Income | -7,829 | -9,430 | -9,998 | -10,190 | -14,223 |
Other Income | 74 | -22 | -253 | 521 | -1,169 |
Pre-tax Income | -7,755 | -9,452 | -10,251 | -9,669 | -15,393 |
Net Income Continuous | -7,755 | -9,452 | -10,251 | -9,669 | -15,393 |
Net Income | $-7,755 | $-9,452 | $-10,251 | $-9,669 | $-15,393 |
EPS Basic Total Ops | -7.08 | -9.00 | -9.60 | -9.20 | -14.41 |
EPS Basic Continuous Ops | -7.18 | -8.90 | -9.68 | -9.13 | -14.53 |
EPS Diluted Total Ops | -7.08 | -9.00 | -9.60 | -9.20 | -14.41 |
EPS Diluted Continuous Ops | -7.18 | -8.90 | -9.68 | -9.13 | -14.53 |
EBITDA(a) | $-7,763 | $-9,361 | $-9,937 | $-10,114 | $-14,167 |